Potent antimyeloma activity of the novel bromodomain inhibitors I-BET151 and I-BET762Aristeidis Chaidos, Anastasios Karadimitris, Antonia Rotolo et al.|Blood|2013Cited by 204
A BET Protein Inhibitor Targeting Mononuclear Myeloid Cells Affects Specific Inflammatory Mediators and Pathways in Crohn’s DiseaseAhmed M I Elfiky, Wouter J. de Jonge, Ishtu Hageman et al.|Cells|2022Cited by 7
Potent Anti-Myeloma Activity Of The Novel Bromodomain Inhibitors I-BET151 and I-BET762Aristeidis Chaidos, Anastasios Karadimitris, Valentina S. Caputo et al.|Blood|2013Cited by 6